We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current KKPCF market cap is 835.65M. The company's latest EPS is JPY 145.1177 and P/E is 0.15.
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Revenue | 94.17B | 89.23B | 74.98B | 76.03B | 72.98B |
Operating Income | 24.59B | 26.22B | 17.79B | 14.07B | 6.11B |
Net Income | 17.78B | 19.37B | 13.41B | 9.55B | 5.44B |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 155.99B | 157.88B | 163.33B | 165.18B | 166.33B |
Total Liabilities | 34.85B | 29.41B | 27.07B | 26.86B | 29.49B |
Total Equity | 121.13B | 128.47B | 136.26B | 138.33B | 136.84B |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Operating | 21.13B | 27.47B | 14.38B | 13.34B | 9.25B |
Investing | -5.74B | -2.53B | -1.65B | -7.89B | -2.63B |
Financing | -9.52B | -10.17B | -8.75B | -8.13B | -6.99B |
Market Cap | 835.65M |
Price to Earnings Ratio | 0.15 |
Price to Sales Ratio | 0.01 |
Price to Cash Ratio | 0.01 |
Price to Book Ratio | 0.01 |
Dividend Yield | - |
Shares Outstanding | 37.47M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -6.50% |
52 Week High | 23.955 |
52 Week Low | 22.30 |
Spread (Intraday) | 1.41 (6.19%) |
Company Name | Kaken Pharmaceutical Company Ltd (PK) |
Address |
2-28-8 honkomagome bunkyo, tokyo 113-8650 |
Website | https://www.kaken.co.jp |
Industry | drugs-health r&d/testing labs (H8) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions